TRIGGER POINT THERAPY PRACTICE BUSINESS PLAN

I. Executive Summary

Company Description

Austin Clinical Trigger Therapy draws its name from the practice city and its focus on evidence-based trigger point and neuromuscular therapy. We operate in the outpatient clinical pain-relief sector, offering targeted manual therapy sessions that prioritize measurable pain reduction over relaxation. Services include thorough intake assessments, individualized treatment plans, and hands-on therapy delivered on professional electric tables by licensed therapists. One-liner: We fix chronic pain, not just relax it.

The practice delivers care through scheduled clinical sessions, documentation of outcomes, and a measurable care pathway designed to scale from 8 to 25 visits per day over five years. What sets us apart is a clinical focus: licensed therapists trained in advanced trigger point protocols, outcome tracking, and longer, results-oriented appointments. Target clients are adults aged 30–65 with chronic musculoskeletal pain, athletes with recurring soft-tissue injuries, and referral networks of primary care and sports medicine clinics. Short-term goal: open in 2026 and reach 8 daily visits by month six. Long-term goal: grow to 25 daily visits, expand staff, and standardize outcome metrics by year five. One-liner: Scale care by tracking outcomes and expanding capacity.

Problem

Chronic and acute pain from muscle knots and trigger points limits mobility and daily function for millions of Americans, driven by postural strain in office workers and overexertion in athletes.

Existing options prioritize temporary symptom relief or general relaxation; there is a gap in access to targeted, clinical-grade neuromuscular care. Patients needing functional restoration lack consistent routes to skilled, results-oriented manual therapy, leading to more healthcare visits, medication use, and delayed recovery.

Solution

Millions of Americans experience persistent muscle pain and limited mobility from untreated trigger points and postural strain, and general relaxation massage commonly fails to resolve these chronic conditions. The practice fills this gap by offering a dedicated clinical facility that prioritizes functional restoration for conditions such as tension headaches, fibromyalgia, and sciatica.

The clinic delivers targeted trigger-point therapy using proven neuromuscular techniques, pairs each session with patient education on self-care and posture, and measures outcomes with range-of-motion and pain scores to drive clinical results. Targeted trigger-point therapy that restores function and reduces chronic pain.

Mission Statement

We deliver clinical-grade neuromuscular therapy focused on targeted trigger point release to help clients overcome chronic pain and restore mobility. We provide measurable results through professional expertise, education, and a therapeutic environment that returns people to active, pain-free lives. We set the standard for clinical excellence in manual therapy and commit to improving quality of life for every client we serve.

Key Success Factors

Success depends on clinical expertise, referral flow, scalable staffing, healthy margins, and cost discipline.

• Exclusive clinical specialization led by the Lead Clinical Therapist driving quality and differentiation.
• Robust referral network with local healthcare professionals ensuring steady high-intent clients.
• Scalable therapist team growth from 1.0 to 5.0 Staff Therapists to meet demand.
• Optimized sales mix and retail revenue growth to $15 per visit by 2030 to sustain margins.
• Financial discipline to achieve breakeven by February 2027 and maintain controlled costs.

Financial Summary

The financial plan shows a clear growth path from first-year revenue of $248,000 to $1,174,000 by 2030.

The plan requires a minimum cash position of $784,000 (reach date: Jan-28) to fund growth; breakeven is Feb-27 (14 months) with a payback of 41 months and an IRR of 2.69%.

Overall, the practice moves to sustained profitability by 2027 and shows positive EBITDA expansion through 2030.

Funding Requirements

Total funding required is $1,167,000 to cover capital expenditures, the Year‑1 operating shortfall, 2026 staffing, and a minimum cash position of $784,000.